Kazuaki Chayama

Active 1991–2025

361
Papers
45,991
Citations
120
h-index
352
i10-index

Citations

Citations per year for Kazuaki Chayama1992: 2 citations1993: 7 citations1994: 24 citations1995: 53 citations1996: 42 citations1997: 55 citations1998: 55 citations1999: 79 citations2000: 84 citations2001: 83 citations2002: 89 citations2003: 143 citations2004: 184 citations2005: 208 citations2006: 211 citations2007: 207 citations2008: 245 citations2009: 260 citations2010: 260 citations2011: 303 citations2012: 359 citations2013: 409 citations2014: 391 citations2015: 402 citations2016: 352 citations2017: 382 citations2018: 324 citations2019: 1,236 citations2020: 1,403 citations2021: 1,442 citations2022: 1,064 citations2023: 758 citations2024: 1,277 citations2025: 497 citations2026: 19 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,166 citing papers, 18.6% of this breakdownJapan: 2,235 citing papers, 13.1% of this breakdownChina: 2,182 citing papers, 12.8% of this breakdownUnited Kingdom: 950 citing papers, 5.6% of this breakdownItaly: 798 citing papers, 4.7% of this breakdownGermany: 729 citing papers, 4.3% of this breakdownFrance: 601 citing papers, 3.5% of this breakdownSouth Korea: 502 citing papers, 2.9% of this breakdownSpain: 401 citing papers, 2.3% of this breakdownCanada: 392 citing papers, 2.3% of this breakdownAustralia: 387 citing papers, 2.3% of this breakdownNetherlands: 349 citing papers, 2% of this breakdown
0%18.6%Other 25.6%

Fields

  • Medicine74.1%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology2.6%
  • Dentistry1.4%
  • Agricultural and Biological Sciences0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Other3.1%

Topics

  • Liver Disease Diagnosis and Treatment8.4%
  • Hepatitis C virus research5%
  • Hepatitis B Virus Studies3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.5%
  • Gastric Cancer Management and Outcomes3.1%
  • Liver Disease and Transplantation2.3%
  • Other73.8%

Coauthors

All papers

Open in search
  1. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Keim, Johannes Wiegand - Journal of Hepatology 2016 cited by 1,246

  2. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ikuyo Kou, Toshihiro Tanaka, Hidewaki Nakagawa, Akari Suzuki, Tomomitsu Hirota, Mayumi Tamari, Kazuaki Chayama, Daiki Miki, Masaki Mori, Satoshi Nagayama, Yataro Daigo, Yoshio Miki, Toyomasa Katagiri, Osamu Ogawa, Wataru Obara, Hidemi Ito, Teruhiko Yoshida, Issei Imoto, Takashi Takahashi, Chizu Tanikawa, Takao Suzuki, Nobuaki Sinozaki, Shiro Minami, Hiroki Yamaguchi, Satoshi Asai, Yasuo Takahashi, Ken Yamaji, Kazuhisa Takahashi, Tomoaki Fujioka, Ryo Takata, Hideki Yanai, Akihide Masumoto, Yukihiro Koretsune, Hiromu Kutsumi, Masahiko Higashiyama, Shigeo Murayama, Naoko Minegishi, Kichiya Suzuki, Kozo Tanno, Atsushi Shimizu, Taiki Yamaji, Motoki Iwasaki, Norie Sawada, Hirokazu Uemura, Keitaro Tanaka, Mariko Naito, Makoto Sasaki, Kenji Wakai, Shoichiro Tsugane, Masayuki Yamamoto, Kazuhiko Yamamoto, Yoshinori Murakami, Yusuke Nakamura, Soumya Raychaudhuri, Johji Inazawa, Toshimasa Yamauchi, Takashi Kadowaki, Michiaki Kubo, Yoichiro Kamatani - Nature Genetics 2020 cited by 588

  3. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2021 cited by 267

  4. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2021 cited by 417

  5. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Genta Nagae, Shogo Yamamoto, Hiroki Ueda, Kenji Tatsuno, Hidenori Ojima, Nobuyoshi Hiraoka, Takuji Okusaka, Michiaki Kubo, Shigeru Marubashi, Terumasa Yamada, Satoshi Hirano, Masakazu Yamamoto, Hideki Ohdan, Kazuaki Shimada, Osamu Ishikawa, Hiroki Yamaue, Kazuaki Chayama, Satoru Miyano, Hiroyuki Aburatani, Tatsuhiro Shibata, Hidewaki Nakagawa - Nature Genetics 2016 cited by 721

  6. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xin Wei Wang, Hidewaki Nakagawa, Mu‐Sheng Zeng, Fan Bai, Ning Zhang - Cancer Cell 2019 cited by 298

  7. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hiroki Yamaue, Kazuaki Chayama, Satoru Miyano, Gad Getz, Aldo Scarpa, Satoshi Hirano, Toru Nakamura, Hidewaki Nakagawa - Journal of Hepatology 2018 cited by 372

  8. Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kazuhiko Koike, Masahiro Kobayashi, Takaaki Higashi, Shigeki Nakagawa, Yo‐ichi Yamashita, Toru Beppu, Hideo Baba, Hiromitsu Kumada, Kazuaki Chayama, Thomas F. Baumert, Yujin Hoshida - Science Translational Medicine 2022 cited by 115

  9. Evidence‐based clinical practice guidelines for liver cirrhosis 2020

    Authors: , , , , , , , , , , , , , , , , , , , , - Hepatology Research 2021 cited by 196

  10. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

    Authors: , , , , , , , , - Journal of Gastroenterology 2012 cited by 560

  11. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bryan C. Fuchs, Yujin Hoshida, Mirjam B. Zeisel, François H.T. Duong, Thomas F. Baumert - Gastroenterology 2019 cited by 269

  12. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

    Authors: , , , , , , , , , , , , , , , , , , - BMC Gastroenterology 2012 cited by 385

  13. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice

    Authors: , , , , , , , , , , , , , , - Journal of Gastroenterology 2013 cited by 150

  14. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shun-ichi Ariizumi, Masakazu Yamamoto, Terumasa Yamada, Kazuaki Chayama, Tomoo Kosuge, Hiroki Yamaue, Naoyuki Kamatani, Satoru Miyano, Hitoshi Nakagama, Yusuke Nakamura, Tatsuhiko Tsunoda, Tatsuhiro Shibata, Hidewaki Nakagawa - Nature Genetics 2012 cited by 876

  15. Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology Research 2021 cited by 143

  16. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2017 cited by 122

  17. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors

    Authors: , , , , , , , , , - Genome Research 2018 cited by 192

  18. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2018 cited by 129

  19. Computer-aided diagnosis of colorectal polyp histology by using a real-time image recognition system and narrow-band imaging magnifying colonoscopy

    Authors: , , , , , , , , , - Gastrointestinal Endoscopy 2015 cited by 246

  20. A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2018 cited by 238

  21. [Endoscopic diagnosis of early gastric cancer].

    Authors: , , , , - 2012 cited by 153

  22. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bryan C. Fuchs, Thomas F. Baumert - Gut 2020 cited by 95

  23. Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hiroshi Aikata, Eisuke Murakami, Toru Beppu, Hideo Baba, rew Warren, Sangeeta N. Bhatia, Masahiro Kobayashi, Hiromitsu Kumada, Austin J. Fobar, Neehar D. Parikh, Jorge A. Marrero, Steve Rwema, Venugopalan D. Nair, Manishkumar Patel, Seunghee Kim‐Schulze, Kathleen E. Corey, Jacqueline G. O’Leary, Göran B. Klintmalm, David L. Thomas, Mohammed Dibas, Gerardo Rodriguez, Bin Zhang, Scott L. Friedman, Thomas F. Baumert, Bryan C. Fuchs, Kazuaki Chayama, Shijia Zhu, Raymond T. Chung, Yujin Hoshida - Gastroenterology 2021 cited by 39

  24. Outcome of endoscopic submucosal dissection for colorectal tumors accompanied by fibrosis

    Authors: , , , , , , - Scandinavian Journal of Gastroenterology 2010 cited by 273